Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,776 | 612 | 93.1% |
| Education | $795.40 | 11 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,364 | 148 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,232 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $1,190 | 68 | $0 (2024) |
| Amgen Inc. | $910.64 | 36 | $0 (2024) |
| UCB, Inc. | $670.84 | 31 | $0 (2024) |
| LEO Pharma Inc. | $669.30 | 39 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $564.42 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $553.98 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $527.38 | 31 | $0 (2024) |
| Lilly USA, LLC | $448.04 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,309 | 164 | ABBVIE INC. ($556.35) |
| 2023 | $3,283 | 183 | ABBVIE INC. ($523.11) |
| 2022 | $3,137 | 162 | ABBVIE INC. ($844.85) |
| 2021 | $1,843 | 114 | AbbVie Inc. ($439.95) |
All Payment Transactions
623 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Immunology | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: ACNE | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Immunology | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 273 | 413 | $29,290 | $10,226 |
| 2022 | 7 | 454 | 677 | $50,312 | $18,398 |
| 2021 | 8 | 386 | 619 | $43,228 | $14,783 |
| 2020 | 9 | 337 | 501 | $33,082 | $12,471 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $8,050 | $2,785 | 34.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 50 | 50 | $6,973 | $2,769 | 39.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 55 | 55 | $5,572 | $1,621 | 29.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 50 | 50 | $4,651 | $1,374 | 29.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 39 | 173 | $1,581 | $669.18 | 42.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 23 | $1,592 | $648.88 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $869.77 | $359.50 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $14,463 | $5,190 | 35.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 88 | 90 | $12,773 | $4,890 | 38.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 90 | 91 | $8,533 | $2,537 | 29.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 46 | 46 | $4,722 | $1,728 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 30 | $3,858 | $1,571 | 40.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 36 | 47 | $3,340 | $1,384 | 41.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 73 | 282 | $2,623 | $1,098 | 41.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 74 | 74 | $10,606 | $4,028 | 38.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 65 | 65 | $10,327 | $3,549 | 34.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 71 | 72 | $6,620 | $1,849 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 43 | $5,550 | $1,513 | 27.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 33 | 33 | $3,386 | $1,366 | 40.4% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 27 | 39 | $2,850 | $1,223 | 42.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 55 | 275 | $2,467 | $907.42 | 36.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 18 | $1,422 | $348.23 | 24.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 64 | 64 | $8,871 | $3,371 | 38.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 58 | 58 | $6,220 | $2,551 | 41.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 58 | 58 | $5,307 | $1,669 | 31.4% |
About Marcy Workman, PA
Marcy Workman, PA is a Medical healthcare provider based in Danville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891751426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marcy Workman, PA has received a total of $11,571 in payments from pharmaceutical and medical device companies, with $3,309 received in 2024. These payments were reported across 623 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($10,776).
As a Medicare-enrolled provider, Workman has provided services to 1,450 Medicare beneficiaries, totaling 2,210 services with total Medicare billing of $55,878. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Danville, KY
- Active Since 04/22/2006
- Last Updated 03/17/2020
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1891751426
Products in Payments
- SKYRIZI (Biological) $1,379
- DUPIXENT (Biological) $1,133
- TREMFYA (Drug) $846.08
- Otezla (Drug) $832.73
- ILUMYA (Biological) $643.21
- RINVOQ (Biological) $633.03
- Sotyktu (Drug) $564.42
- ADBRY (Biological) $518.60
- TALTZ (Drug) $401.30
- REMICADE (Biological) $343.51
- Bimzelx (Biological) $339.41
- Cimzia (Drug) $331.43
- HUMIRA (Biological) $331.36
- EUCRISA (Drug) $259.76
- COSENTYX (Drug) $228.48
- VTAMA (Drug) $216.87
- Ilumya (Biological) $193.95
- Zoryve (Drug) $175.35
- COSENTYX (Biological) $171.19
- OPZELURA (Drug) $155.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Danville
Thomas Iacovoni, Pa-C, PA-C
Medical — Payments: $66,238
Audrey Jeon Jeon
Medical — Payments: $8,147
Chang Zou, Pa-C, PA-C
Medical — Payments: $6,510
Miss. Kelly London, Pa-C, PA-C
Medical — Payments: $4,822
Ms. Angela Lively, Pa-C, PA-C
Medical — Payments: $4,636
Mariah Lomax, Pa-C, PA-C
Medical — Payments: $4,158